ASPIRA WOMEN'S HEALTH INC (AWH)
US04537Y2081 - Common Stock
We assign a fundamental rating of 2 out of 10 to AWH. AWH was compared to 196 industry peers in the Health Care Equipment & Supplies industry. AWH may be in some trouble as it scores bad on both profitability and health. AWH shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year AWH has reported negative net income.
AWH had a negative operating cash flow in the past year.
In the past 5 years AWH always reported negative net income.
AWH had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of AWH (-266.67%) is worse than 96.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -266.67% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-166.57%
ROA(5y)-140.3%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AWH has a Gross Margin (57.52%) which is comparable to the rest of the industry.
AWH's Gross Margin has improved in the last couple of years.
AWH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 57.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y29.18%
GM growth 5YN/A
2. Health
2.1 Basic Checks
AWH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AWH has more shares outstanding
The number of shares outstanding for AWH has been increased compared to 5 years ago.
AWH has a worse debt/assets ratio than last year.
2.2 Solvency
AWH has an Altman-Z score of -121.78. This is a bad value and indicates that AWH is not financially healthy and even has some risk of bankruptcy.
AWH has a worse Altman-Z score (-121.78) than 95.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -121.78 |
ROIC/WACCN/A
WACC9.58%
2.3 Liquidity
A Current Ratio of 1.03 indicates that AWH should not have too much problems paying its short term obligations.
AWH has a worse Current ratio (1.03) than 91.84% of its industry peers.
AWH has a Quick Ratio of 1.03. This is a bad value and indicates that AWH is not financially healthy enough and could expect problems in meeting its short term obligations.
AWH's Quick ratio of 0.99 is on the low side compared to the rest of the industry. AWH is outperformed by 84.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 55.80% over the past year.
The Revenue has grown by 11.98% in the past year. This is quite good.
AWH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.58% yearly.
EPS 1Y (TTM)55.8%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q50%
Revenue 1Y (TTM)11.98%
Revenue growth 3Y25.33%
Revenue growth 5Y24.58%
Revenue growth Q2Q-0.93%
3.2 Future
Based on estimates for the next years, AWH will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.53% on average per year.
The Revenue is expected to grow by 60.47% on average over the next years. This is a very strong growth
EPS Next Y24.2%
EPS Next 2Y19.04%
EPS Next 3Y16.53%
EPS Next 5YN/A
Revenue Next Year14.53%
Revenue Next 2Y43.32%
Revenue Next 3Y51.75%
Revenue Next 5Y60.47%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AWH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AWH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as AWH's earnings are expected to grow with 16.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.04%
EPS Next 3Y16.53%
5. Dividend
5.1 Amount
No dividends for AWH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ASPIRA WOMEN'S HEALTH INC
NASDAQ:AWH (4/19/2024, 7:00:00 PM)
3.49
-0.04 (-1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap36.09M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -266.67% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 57.52% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)55.8%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y24.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.98%
Revenue growth 3Y25.33%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y